Technical Analysis for MRK - Merck & Company, Inc.

Grade Last Price % Change Price Change
grade A 58.83 0.32% 0.19
MRK closed up 0.32 percent on Friday, April 20, 2018, on 80 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Earnings due: May 1

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical MRK trend table...

Date Alert Name Type % Chg
Apr 20 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Apr 20 NR7 Range Contraction 0.00%
Apr 20 Inside Day Range Contraction 0.00%
Apr 20 Overbought Stochastic Strength 0.00%
Apr 19 200 DMA Support Bullish 0.32%
Apr 19 Upper Bollinger Band Walk Strength 0.32%
Apr 19 Overbought Stochastic Strength 0.32%
Apr 18 Stochastic Sell Signal Bearish -0.15%
Apr 18 Slingshot Bullish Bullish Swing Setup -0.15%
Apr 18 Upper Bollinger Band Walk Strength -0.15%

Older signals for MRK ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Merck & Co., Inc. provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide. It offers human health pharmaceutical products, such as therapeutic and preventive agents for the treatment of human disorders in the areas of cardiovascular, diabetes and obesity, respiratory, women's health and endocrine, inflammatory and infectious diseases, oncology, ophthalmology, and others. The company also provides vaccines, including preventive pediatric, adolescent, and adult vaccines. In addition, it discovers, develops, manufactures, and markets animal health products comprising vaccines, antibiotics, and anti-inflammatory drugs for respiratory diseases, as well as products for the treatment of fertility disorders. Further, the company manufactures and sells over-the-counter products consisting of non-drowsy antihistamines; decongestant-free cold/flu medicine for people with high blood pressure; nasal decongestant spray; and products for occasional constipation and frequent heartburn. Additionally, it offers foot care products, including topical antifungal, and foot and sneaker odor/wetness products; and sun care products, such as sun care lotions, sprays, and dry oils. The company serves drug wholesalers and retailers, hospitals, government agencies, physicians, physician distributors, veterinarians, animal producers, food chain and mass merchandiser outlets, club stores, and specialty channels, as well as managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions. It has a collaboration with Sanofi Pasteur S.A. and Abide Therapeutics, Inc.; and has a collaboration and license agreement with Luminex Corporation. The company was founded in 1891 and is headquartered in Whitehouse Station, New Jersey.
Is MRK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 65.2791
52 Week Low 52.6595
Average Volume 12,004,702
200-Day Moving Average 58.4354
50-Day Moving Average 55.0682
20-Day Moving Average 55.881
10-Day Moving Average 57.707
Average True Range 1.1911
ADX 21.19
+DI 32.77
-DI 17.62
Chandelier Exit (Long, 3 ATRs ) 56.3867
Chandelier Exit (Short, 3 ATRs ) 56.4033
Upper Bollinger Band 59.9872
Lower Bollinger Band 51.7748
Percent B (%b) 0.86
BandWidth 14.696229
MACD Line 1.097
MACD Signal Line 0.6656
MACD Histogram 0.4314
Fundamentals Value
Market Cap 160.45 Billion
Num Shares 2.73 Billion
EPS 1.85
Price-to-Earnings (P/E) Ratio 31.80
Price-to-Sales 4.23
Price-to-Book 4.28
PEG Ratio 2.67
Dividend 1.88
Dividend Yield 3.20%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 59.75
Resistance 3 (R3) 59.79 59.53 59.59
Resistance 2 (R2) 59.53 59.30 59.51 59.54
Resistance 1 (R1) 59.18 59.15 59.05 59.14 59.49
Pivot Point 58.92 58.92 58.86 58.90 58.92
Support 1 (S1) 58.57 58.69 58.44 58.53 58.17
Support 2 (S2) 58.31 58.54 58.29 58.12
Support 3 (S3) 57.96 58.31 58.07
Support 4 (S4) 57.92